Menu

• Ask a Health Expert about CULTURE URINE POSITIVE
• Post Your Side Effect related to CULTURE URINE POSITIVE
• CULTURE URINE POSITIVE and FDA Warnings
• CULTURE URINE POSITIVE in Patients Wiki
• Report CULTURE URINE POSITIVE in Drug Side Effect Survey

CULTURE URINE POSITIVE side effect

What is CULTURE URINE POSITIVE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Carboplatin Side Effects Report #5652729-5
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Mar 05, 2008. Female patient, weighting 214.5 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: culture urine positive, deep vein thrombosis, dehydration, infection, pulmonary embolism, pyrexia, syncope, . CARBOPLATIN dosage: 725 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.

Flurazepam Side Effects Report #5656214-6
FLURAZEPAM problem was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Feb 21, 2008. Female patient, 29 years of age, was diagnosed with schizophrenia and was treated with FLURAZEPAM. After drug was administered, patient experienced the following problems/side effects: culture urine positive, dysuria, enterobacter infection, klebsiella infection, pseudomonas infection, toxic epidermal necrolysis, urinary retention, wound infection staphylococcal, . FLURAZEPAM dosage: unknown. During the same period patient was treated with PROMAZINE HYDROCHLORIDE, OLANZAPINE, FLUPHENAZINE, DIAZEPAM, BIPERIDEN HYDROCHLORIDE, CARBAMAZEPINE. Patient was hospitalized. Patient recovered.

Rebetol Side Effects Report #5522150-9
Physician from JAPAN reported REBETOL problem on Nov 07, 2007. Male patient, 59 years of age, weighting 123.5 lb, was diagnosed with hepatitis c and was treated with REBETOL. After drug was administered, patient experienced the following problems/side effects: culture urine positive, decreased appetite, extradural abscess, haemoglobin decreased, hypoalbuminaemia, intervertebral discitis, malaise, nasopharyngitis, neutrophil count decreased, . REBETOL dosage: PO ; 800 MG;QD;PO ; 600 MG;QD;PO. During the same period patient was treated with INTRON A, INTRON A, INTRON A, INTRON A, INTRON A, GLYCYRON. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5533645-6
VELCADE problem was reported by a Physician from GREECE on Nov 20, 2007. Female patient, 81 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: culture urine positive, fatigue, flatulence, proteus infection, vomiting, . VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.


Reyataz Side Effects Report #5473118-2
Health Professional from FRANCE reported REYATAZ problem on Sept 25, 2007. Male patient, 63 years of age, was diagnosed with epilepsy, depression and was treated with REYATAZ. After drug was administered, patient experienced the following problems/side effects: culture urine positive, dysuria, haematuria, hypercalciuria, hypercreatininaemia, . REYATAZ dosage: unknown. During the same period patient was treated with INEXIUM, TRIFLUCAN, DEPAKENE, SEROPRAM, BACTRIM DS. Patient was hospitalized. Patient died on 07/13/2007.

Cyclophosphamide Side Effects Report #5503918-1
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2007. Male patient, weighting 167.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: culture urine positive, klebsiella infection, . CYCLOPHOSPHAMIDE dosage: 1965 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5474710-1
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Sept 27, 2007. Female patient, weighting 134.3 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: culture urine positive, haematocrit decreased, haemoglobin decreased, pyrexia, staphylococcal infection, urinary retention, . CISPLATIN dosage: 84 MG. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5381496-8
CETUXIMAB problem was reported by a Health Professional from UNITED STATES on July 05, 2007. Male patient, 58 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: culture urine positive, disease progression, dyspnoea, performance status decreased, pyrexia, . CETUXIMAB dosage: 250MG/M2 425MG WEEKLY IV. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5402785-4
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on July 30, 2007. Female patient, weighting 210.4 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: culture urine positive, diarrhoea, escherichia infection, fatigue, neutrophil percentage increased, pulmonary embolism, . CISPLATIN dosage: 100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.


Cetuximab Side Effects Report #5381496-8
CETUXIMAB problem was reported by a Health Professional from UNITED STATES on July 05, 2007. Male patient, 58 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: culture urine positive, disease progression, dyspnoea, performance status decreased, pyrexia, . CETUXIMAB dosage: 250MG/M2 425MG WEEKLY IV. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5402785-4
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on July 30, 2007. Female patient, weighting 210.4 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: culture urine positive, diarrhoea, escherichia infection, fatigue, neutrophil percentage increased, pulmonary embolism, . CISPLATIN dosage: 100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5764138-9
CLOLAR problem was reported by a Physician from UNITED STATES on May 30, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: culture urine positive, dialysis, enterococcal infection, enterococcal sepsis, neutropenic sepsis, renal failure, respiratory failure, staphylococcal infection, staphylococcal sepsis, . CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, CALCIUM ACETATE, DEXAMETHASONE PHOSPHATE, FLUCONAZOLE, ACETAMINOPHEN, ACYCLOVIR, ALBUTEROL SULPHATE, ESCITALOPRAM OXALATE. Patient died on 04/08/2008.

Clolar Side Effects Report #5738493-X
Physician from UNITED STATES reported CLOLAR problem on May 07, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: culture urine positive, dialysis, enterococcal infection, hypoxia, neutropenic infection, renal failure, respiratory failure, sepsis syndrome, staphylococcal infection, . CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, CALCIUM ACETATE, DEXAMETHASONE PHOSPHATE, FLUCONAZOLE, ACETAMINOPHEN, ACYCLOVIR, ESCITALOPRAM. Patient died on 04/08/2008.

Abatacept Side Effects Report #5310128-X
ABATACEPT problem was reported by a Health Professional from SPAIN on Apr 24, 2007. Female patient, 72 years of age, was diagnosed with rheumatoid arthritis and was treated with ABATACEPT. After drug was administered, patient experienced the following problems/side effects: culture urine positive, enterococcal infection, urinary tract infection, . ABATACEPT dosage: unknown. Patient was hospitalized. Patient recovered.


Natalizumab Side Effects Report #5257262-0
Physician from UNITED STATES reported NATALIZUMAB problem on Feb 19, 2007. Female patient, 41 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: culture urine positive, jc virus infection, . NATALIZUMAB dosage: unknown. Patient recovered.

Velcade Side Effects Report #5262155-9
VELCADE problem was reported by a Health Professional from FRANCE on Mar 02, 2007. Female patient, 59 years of age, was diagnosed with myelodysplastic syndrome and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: culture urine positive, eyelid oedema, hidradenitis, injection site oedema, injection site reaction, klebsiella infection, laryngeal oedema, lymphangitis, rash erythematous, . VELCADE dosage: unknown. During the same period patient was treated with CYTARABINE, LOGIMAX, CORVASAL, INFLUENZA VACCINE. Patient was hospitalized. Patient recovered.

Enalapril Side Effects Report #5273274-5
Health Professional from FRANCE reported ENALAPRIL MALEATE problem on Mar 02, 2007. Female patient, 80 years of age, was diagnosed with hypertension, osteoporosis and was treated with ENALAPRIL MALEATE. After drug was administered, patient experienced the following problems/side effects: culture urine positive, escherichia infection, tubulointerstitial nephritis, . ENALAPRIL MALEATE dosage: 20 MG QD PO. During the same period patient was treated with FOSAMAX, RABEPRAZOLE, BUDESONIDE, CETIRIZINE HYDROCHLORIDE, FENOFIBRATE, FERROUS SO, FLUINDIONE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Enalapril Side Effects Report #5286952-9
ENALAPRIL MALEATE problem was reported by a Physician from FRANCE on Mar 13, 2007. Female patient, 80 years of age, was diagnosed with hypertension, osteoporosis and was treated with ENALAPRIL MALEATE. After drug was administered, patient experienced the following problems/side effects: culture urine positive, escherichia infection, pollakiuria, tubulointerstitial nephritis, . ENALAPRIL MALEATE dosage: 20 MG QD PO. During the same period patient was treated with FOSAMAX, RABEPRAZOLE, BUDESONIDE, CETIRIZINE HYDROCHLORIDE, FENOFIBRATE, FERROUS SO, FLUINDIONE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5671222-7
Health Professional from UNITED STATES reported REVLIMID problem on Mar 05, 2008. Female patient, 85 years of age, weighting 143.5 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: confusional state, culture urine positive, cystitis, diverticulitis, fluid overload, haemoglobin decreased, headache, hypocalcaemia, hypokalaemia, . REVLIMID dosage: 15 MG, QD, ORAL; 10 MG, ORAL; 25 MG, QD X21 DAYS, ORAL. During the same period patient was treated with DEXAMETHASONE, COUMADIN, BACTRIM DS, ASPIRIN. Patient was hospitalized. Patient died on 04/25/2007.


Tysabri Side Effects Report #5671724-3
TYSABRI problem was reported by a Health Professional from UNITED STATES on Mar 04, 2008. Female patient, 57 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: asthenia, culture urine positive, dyspnoea, oedema peripheral, proteus infection, urinary tract infection bacterial, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

Tacrolimus Side Effects Report #5634031-0
Health Professional from UNITED KINGDOM reported TACROLIMUS problem on Jan 31, 2008. Male patient, 54 years of age, was diagnosed with renal transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, culture urine positive, cytomegalovirus infection, escherichia urinary tract infection, graft complication, hemiparesis, ureteral necrosis, urinary fistula, weight decreased, . TACROLIMUS dosage: 6 MG, ORAL; 4 MG, ORAL; 5 MG, UID/QD,. During the same period patient was treated with DACLIZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5635609-0
SORAFENIB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2008. Male patient, 67 years of age, weighting 205.0 lb, was diagnosed with thyroid cancer metastatic and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, culture urine positive, pyrexia, tachycardia, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5636217-8
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 20, 2008. Female patient, weighting 141.3 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: chills, culture urine positive, escherichia infection, pharyngolaryngeal pain, pyrexia, . CISPLATIN dosage: 83 MG. During the same period patient was treated with NAVELBINE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5607604-9
ERBITUX problem was reported by a Health Professional from UNITED STATES on Jan 28, 2008. Male patient, weighting 179.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: blood culture positive, culture urine positive, hyponatraemia, malignant neoplasm progression, pericardial effusion malignant, renal failure, respiratory failure, sputum culture positive, . ERBITUX dosage: unknown. During the same period patient was treated with DASATINIB BMS. Patient was hospitalized. Patient died on 01/15/2008.

Doxorubicin Side Effects Report #5611925-3
Consumer or non-health professional from UNITED STATES reported DOXORUBICIN HYDROCHLORIDE problem on Jan 31, 2008. Male patient, weighting 173.9 lb, was treated with DOXORUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, culture urine positive, escherichia infection, fatigue, haemoglobin decreased, mucosal inflammation, serratia infection, staphylococcal infection, streptococcal infection, . DOXORUBICIN HYDROCHLORIDE dosage: 80 MG. During the same period patient was treated with GEMCITABINE, TAXOL, NEULASTA. Patient was hospitalized. Patient recovered.

Rabeprazole Side Effects Report #5612019-3
RABEPRAZOLE problem was reported by a Health Professional from FRANCE on Jan 14, 2008. Female patient, 78 years of age, was diagnosed with sicca syndrome and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, culture urine positive, inflammation, nephritis interstitial, rash papular, renal failure acute, . RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PLAQUENIL, FOSAMAX, ATARAX, LERCANIDIPINE, CACIT, PHYLARM, COLPOTROPHINE, OFLOXACIN. Patient was hospitalized. Patient recovered.

Citalopram Side Effects Report #5550872-2
Health Professional from DENMARK reported CITALOPRAM HYDROBROMIDE problem on Jan 28, 2004. Male patient, weighting 8.16 lb, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: ammonia increased, culture urine positive, escherichia infection, feeding disorder neonatal, maternal condition affecting foetus, protein urine present, . CITALOPRAM HYDROBROMIDE dosage: 10 MG QD TRANSPLACENTAL. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5451358-6
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Female patient, weighting 150.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, culture urine positive, haematocrit decreased, haemoglobin decreased, nausea, neutrophil count increased, vomiting, white blood cell count increased, . CYCLOPHOSPHAMIDE dosage: 1080 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5452129-7
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Sept 12, 2007. Female patient, weighting 95.99 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, culture urine positive, escherichia infection, nausea, renal failure acute, vomiting, . CISPLATIN dosage: 43 MG. During the same period patient was treated with ERBITUX. Patient was hospitalized. Patient recovered.

Cefaclor Side Effects Report #5468098-X
CEFACLOR problem was reported by a Health Professional from SINGAPORE on Sept 05, 2007. Female patient, 72 years of age, was diagnosed with skin ulcer and was treated with CEFACLOR. After drug was administered, patient experienced the following problems/side effects: culture urine positive, cystitis haemorrhagic, enterobacter infection, escherichia infection, pathogen resistance, type iv hypersensitivity reaction, . CEFACLOR dosage: unknown. During the same period patient was treated with ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN ETHYLSUCCINATE, BACTRIM, MEROPENEM. Patient was hospitalized. Patient recovered.

Topotecan Side Effects Report #5409431-4
Consumer or non-health professional from UNITED STATES reported TOPOTECAN problem on Aug 07, 2007. Female patient, weighting 134.1 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, culture urine positive, diarrhoea, flank pain, ill-defined disorder, trichosporon infection, . TOPOTECAN dosage: 15.9 MG. During the same period patient was treated with CIPRO, FENTANYL, LOVENOX, NICODERM, PERCOCET, PHENERGAN. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5442910-2
REBIF problem was reported by a Consumer or non-health professional from FRANCE on Aug 17, 2007. Female patient, 38 years of age, was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cellulitis, culture urine positive, escherichia infection, injection site inflammation, injection site nodule, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

Taxotere Side Effects Report #5378367-X
Consumer or non-health professional from UNITED STATES reported TAXOTERE problem on July 02, 2007. Male patient, weighting 251.3 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, culture urine positive, gastrointestinal haemorrhage, . TAXOTERE dosage: 163 MG. Patient was hospitalized. Patient recovered.

Ciprofloxacin Side Effects Report #5386422-3
CIPROFLOXACIN problem was reported by a Physician from SINGAPORE on June 28, 2007. Male patient, 34 years of age, was diagnosed with urinary tract infection and was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: contracted bladder, culture urine positive, cystoscopy abnormal, dysuria, tuberculosis, . CIPROFLOXACIN dosage: unknown. Patient recovered.

Taxotere Side Effects Report #5378367-X
Consumer or non-health professional from UNITED STATES reported TAXOTERE problem on July 02, 2007. Male patient, weighting 251.3 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, culture urine positive, gastrointestinal haemorrhage, . TAXOTERE dosage: 163 MG. Patient was hospitalized. Patient recovered.

Ciprofloxacin Side Effects Report #5386422-3
CIPROFLOXACIN problem was reported by a Physician from SINGAPORE on June 28, 2007. Male patient, 34 years of age, was diagnosed with urinary tract infection and was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: contracted bladder, culture urine positive, cystoscopy abnormal, dysuria, tuberculosis, . CIPROFLOXACIN dosage: unknown. Patient recovered.

Cisplatin Side Effects Report #5775276-9
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on June 16, 2008. Female patient, weighting 125.9 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, culture urine positive, escherichia infection, inappropriate antidiuretic hormone secretion, pancytopenia, urinary retention, . CISPLATIN dosage: 119 MG. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5787472-5
CLOLAR problem was reported by a Physician from UNITED STATES on June 12, 2008. Female patient, 60 years of age, weighting 199.7 lb, was diagnosed with myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, culture urine positive, dysuria, enterococcal infection, graft versus host disease, intervertebral disc protrusion, micturition urgency, pseudomonas infection, . CLOLAR dosage: 67 MG, QDX5, INTRAVENOUS. During the same period patient was treated with PHENYTOIN, MICAFUNGIN, DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE, AZTREONAM. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5701645-9
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Apr 09, 2008. Female patient, weighting 98.11 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: blood aldosterone decreased, culture urine positive, dehydration, fatigue, hydronephrosis, hyperhidrosis, loss of consciousness, orthostatic hypotension, renin decreased, . CARBOPLATIN dosage: 505 MG. During the same period patient was treated with TAXOL, ATIVAN, TRAMADOL, ZOFRAN, AMPICILLIN, ESTROGEN, LOMOTIL, XANAX. Patient was hospitalized. Patient recovered.

Iressa Side Effects Report #5368386-1
IRESSA problem was reported by a Health Professional from UNITED STATES on June 22, 2007. Female patient, 15 years of age, weighting 88.18 lb, was diagnosed with adenocarcinoma and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: blood urine present, culture urine positive, haematemesis, haematocrit decreased, haemoglobin decreased, nausea, neutrophil count decreased, occult blood positive, prothrombin time prolonged, . IRESSA dosage: 200 MG QD X 12 DAYS PO. During the same period patient was treated with IRINOTECAN, FENTANYL, ELITEK, METHADONE, ONDANSETRON, OMEPRAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MEPHYTON. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5374038-4
Physician from UNITED STATES reported REVLIMID problem on June 18, 2007. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arthralgia, culture urine positive, oral infection, platelet count decreased, pneumonia parainfluenzae viral, staphylococcal infection, stress fracture, tibia fracture, . REVLIMID dosage: unknown. During the same period patient was treated with ALBUTEROL, BACTRIM, PROTONIX, PREDNISONE, DILAUDID, ADVIL LIQUI. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5325406-8
AVONEX problem was reported by a Physician from UNITED STATES on Apr 26, 2007. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: blood culture positive, culture urine positive, sepsis, . AVONEX dosage: unknown. Patient recovered.

Cisplatin Side Effects Report #5315645-4
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Apr 30, 2007. Female patient, weighting 92.81 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: asthenia, culture urine positive, haemoglobin decreased, oral intake reduced, platelet count decreased, pyrexia, white blood cell count decreased, . CISPLATIN dosage: 65 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5281555-4
GEMCITABINE problem was reported by a Health Professional from UNITED STATES on Mar 23, 2007. Female patient, 66 years of age, weighting 129.2 lb, was diagnosed with sarcoma uterus and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: catheter related infection, culture urine positive, escherichia sepsis, hyponatraemia, thrombocytopenia, . GEMCITABINE dosage: 1520 MG D1+ D8 EVERY 21 DAYS IV. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5672511-2
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Mar 18, 2008. Female patient, weighting 134.5 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: beta haemolytic streptococcal infection, blood culture positive, culture urine positive, febrile neutropenia, mucosal inflammation, platelet count decreased, white blood cell count decreased, . FLUOROURACIL dosage: 3060 MG. During the same period patient was treated with MITOMYCIN. Patient was hospitalized. Patient recovered.

Oxaliplatin Side Effects Report #5614936-7
OXALIPLATIN problem was reported by a Physician from UNITED STATES on Feb 04, 2008. Male patient, 68 years of age, weighting 243.0 lb, was diagnosed with squamous cell carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: autonomic neuropathy, cellulitis, culture urine positive, dizziness postural, orthostatic hypotension, . OXALIPLATIN dosage: 130MG/M2=260MG EVERY 3 WKS IV. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5621911-5
Physician from UNITED STATES reported CLOFARABINE problem on Jan 23, 2008. Female patient, 66 years of age, weighting 210.3 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, blood pressure increased, culture urine positive, dehydration, diarrhoea, fluid overload, gastrointestinal haemorrhage, laboratory test interference, lung neoplasm, . CLOFARABINE dosage: 30 MG/M2, QDX5, INTRAVENOUS, 20 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with ESTRADIOL, SYNTHROID, LIPITOR, METOPROLOL TARTRATE, AMIKACIN, PROTONIX, VALTREX. Patient was hospitalized. Patient recovered.

Januvia Side Effects Report #5630649-X
JANUVIA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Male patient, 59 years of age, weighting 196.0 lb, was treated with JANUVIA. After drug was administered, patient experienced the following problems/side effects: balanoposthitis, blood glucose increased, culture urine positive, leukocytoclastic vasculitis, penile abscess, penile infection, penile necrosis, penis disorder, . JANUVIA dosage: 100 MG/DAILY/PO. During the same period patient was treated with HUMULIN R, HUMULIN R, LISINOPRIL, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Augmentin Side Effects Report #5639768-5
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on Feb 11, 2008. Female patient, 30 years of age, was diagnosed with cystitis escherichia and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: chills, clostridium difficile toxin test positive, culture urine positive, diarrhoea, escherichia infection, pyrexia, rectal haemorrhage, . AUGMENTIN dosage: unknown. Patient was hospitalized. Patient recovered.

Norvir Side Effects Report #5581002-9
NORVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2007. Female patient, 30 years of age, was treated with NORVIR. After drug was administered, patient experienced the following problems/side effects: bacillus infection, chorioamnionitis, culture urine positive, cytomegalovirus antibody positive, endometritis, funisitis, herpes simplex serology positive, placental infarction, urosepsis, . NORVIR dosage: unknown. During the same period patient was treated with TRUVADA, ATAZANAVIR SULPHATE. Patient recovered.

Cap Side Effects Report #5594196-6
Physician from UNITED STATES reported CAP VORINOSTAT UNK problem on Dec 03, 2007. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with CAP VORINOSTAT UNK. After drug was administered, patient experienced the following problems/side effects: benign prostatic hyperplasia, confusional state, culture urine positive, cystitis, mental status changes, pneumonia, renal failure acute, staphylococcal infection, urinary retention, . CAP VORINOSTAT UNK dosage: 400 MG/DAILY/PO; 400 MG/DAILY/PO. During the same period patient was treated with CAP VORINOSTAT UNK, IMODIUN, MIRALAX, REGLAN, VALTREX, ZOLOFT, ASPIRIN. Patient was hospitalized. Patient recovered.